수의 심장학 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 동물 유형별, 제품별, 적응증별, 최종 용도별, 지역별＆경쟁(2021-2031년)

The Global Veterinary Cardiology Market is projected to expand from USD 2.83 Billion in 2025 to USD 4.71 Billion by 2031, registering a CAGR of 8.86%. This sector encompasses specialized diagnostics, pharmaceuticals, and therapies aimed at detecting and treating heart conditions in companion animals. Growth is largely fueled by the increasing prevalence of cardiac issues in aging pets and the strengthening emotional bond between humans and animals, which encourages owners to pursue advanced medical care. According to the American Pet Products Association, spending on veterinary care and products hit $39.8 billion in 2024, creating a solid economic base that allows clinics to invest in cardiac services and modern diagnostics.

Despite these positive indicators, the market confronts a major obstacle due to the significant expenses involved in specialized cardiac care. The substantial investment needed for advanced echocardiography equipment, combined with the costs of complex surgeries, often restricts access for pet owners with limited budgets. These economic hurdles narrow the potential patient pool and threaten to stall the broader adoption of high-end cardiology solutions, particularly in areas where price sensitivity is high.

Market Driver

Advancements in technology for veterinary cardiac imaging and diagnostics are reshaping the industry by facilitating the earlier and more precise identification of complex heart disorders. Modern innovations in echocardiography, ECG monitoring, and biomarker analysis allow vets to diagnose conditions like mitral valve disease before symptoms escalate, while the addition of AI support improves clinical decision-making and equipment adoption. Data from IDEXX Laboratories in October 2024 highlighted a 10% annual increase in their global premium instrument installed base, illustrating this trend. Furthermore, a Nationwide report from April 2024 identified valvular heart disease as the eighth most common condition in dogs, underscoring the necessity for such accurate detection capabilities.

The broadening scope of pet insurance is also enhancing access to specialty care, acting as a crucial financial buffer for owners dealing with the high costs of long-term heart management. As policies increasingly cover specialist referrals and chronic conditions, owners are better positioned to afford life-extending treatments like pacemakers or lifelong medication that were once financially out of reach. This expanded coverage directly boosts revenue for specialty clinics and drug manufacturers. As reported by the North American Pet Health Insurance Association in April 2024, the industry saw $4.27 billion in total premiums in 2023, signaling a significant rise in available funds for advanced veterinary healthcare.

Market Challenge

The most significant hurdle facing the Global Veterinary Cardiology Market is the prohibitive cost associated with specialized cardiac services. Because veterinary practices must invest heavily to acquire advanced diagnostic tools like echocardiography systems and perform complex interventions, they are compelled to charge higher fees, placing a strain on pet owners. This financial pressure renders specialized cardiac procedures unattainable for many, particularly in areas with low pet insurance coverage or for individuals with limited disposable income.

These economic barriers directly constrain the addressable market and hinder the widespread uptake of premium cardiology solutions. When treatment costs surpass an owner's budget, they are often forced to delay or refuse essential care, leading to a reduction in the volume of cardiac services rendered. According to the American Veterinary Medical Association, veterinary practices saw a 2.3% drop in patient visits in 2024, largely due to rising prices. This decline demonstrates how escalating costs effectively block a portion of the market from accessing services, thereby impeding the sector's growth potential.

Market Trends

The rise of minimally invasive interventional procedures is revolutionizing the market by offering safer, catheter-based options instead of high-risk open-heart surgeries. Veterinarians are increasingly utilizing advanced methods, such as transcatheter edge-to-edge repair, to manage complex issues like mitral valve disease, resulting in less trauma and faster recovery for aging pets. This shift toward premium modalities is driving a noticeable increase in both the use and cost of specialized care. A July 2025 report by Trupanion noted that cardiology claims for dogs jumped by 55%, with the average claim value rising by 34%, highlighting the strong market movement toward these sophisticated interventional services.

Concurrently, the growth of tele-cardiology and remote consulting services is helping general practitioners bridge diagnostic gaps by providing seamless access to cardiac specialists. This model depends on integrated cloud-based systems that allow for the instant sharing of ECG and echocardiogram data for expert review, requiring significant investment in digital infrastructure. The push for this connected care model is directly boosting revenue for technology providers. For instance, IDEXX Laboratories reported in February 2025 that revenue from veterinary software, services, and diagnostic imaging grew by 13%, emphasizing the vital role digital platforms play in the expanding tele-cardiology landscape.

Key Market Players

• Boehringer Ingelheim International GmbH
• Jurox Pty Limited
• Ceva Animal Health, LLC
• Merck & Co., Inc.
• IDEXX
• Apex Bio Medicals
• SOUND
• GE HealthCare
• FUJIFILM Holdings America Corporation
• ESAOTE SPA

Report Scope

In this report, the Global Veterinary Cardiology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Cardiology Market, By Animal Type

• Companion Animals
• Production Animals

Veterinary Cardiology Market, By Product

• Pharmaceuticals
• Diagnostics

Veterinary Cardiology Market, By Indication

• Congestive Heart Failure
• Myocardial Disease
• Arrythmias
• Others

Veterinary Cardiology Market, By End Use

• Veterinary Hospitals & Clinics
• Others

Veterinary Cardiology Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Cardiology Market.

Available Customizations:

Global Veterinary Cardiology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Cardiology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Companion Animals, Production Animals)
  • 5.2.2. By Product (Pharmaceuticals, Diagnostics)
  • 5.2.3. By Indication (Congestive Heart Failure, Myocardial Disease, Arrythmias, Others)
  • 5.2.4. By End Use (Veterinary Hospitals & Clinics, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Veterinary Cardiology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Product
  • 6.2.3. By Indication
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Veterinary Cardiology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Indication
      • 6.3.1.2.4. By End Use
  • 6.3.2. Canada Veterinary Cardiology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Indication
      • 6.3.2.2.4. By End Use
  • 6.3.3. Mexico Veterinary Cardiology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Indication
      • 6.3.3.2.4. By End Use

7. Europe Veterinary Cardiology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Product
  • 7.2.3. By Indication
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Veterinary Cardiology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Indication
      • 7.3.1.2.4. By End Use
  • 7.3.2. France Veterinary Cardiology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Indication
      • 7.3.2.2.4. By End Use
  • 7.3.3. United Kingdom Veterinary Cardiology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Indication
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy Veterinary Cardiology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Indication
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain Veterinary Cardiology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Indication
      • 7.3.5.2.4. By End Use

8. Asia Pacific Veterinary Cardiology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Product
  • 8.2.3. By Indication
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Veterinary Cardiology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Indication
      • 8.3.1.2.4. By End Use
  • 8.3.2. India Veterinary Cardiology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Indication
      • 8.3.2.2.4. By End Use
  • 8.3.3. Japan Veterinary Cardiology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Indication
      • 8.3.3.2.4. By End Use
  • 8.3.4. South Korea Veterinary Cardiology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Indication
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia Veterinary Cardiology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Indication
      • 8.3.5.2.4. By End Use

9. Middle East & Africa Veterinary Cardiology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Product
  • 9.2.3. By Indication
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Veterinary Cardiology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Indication
      • 9.3.1.2.4. By End Use
  • 9.3.2. UAE Veterinary Cardiology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Indication
      • 9.3.2.2.4. By End Use
  • 9.3.3. South Africa Veterinary Cardiology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Indication
      • 9.3.3.2.4. By End Use

10. South America Veterinary Cardiology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type
  • 10.2.2. By Product
  • 10.2.3. By Indication
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Veterinary Cardiology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Indication
      • 10.3.1.2.4. By End Use
  • 10.3.2. Colombia Veterinary Cardiology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Indication
      • 10.3.2.2.4. By End Use
  • 10.3.3. Argentina Veterinary Cardiology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Indication
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Veterinary Cardiology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boehringer Ingelheim International GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Jurox Pty Limited
• 15.3. Ceva Animal Health, LLC
• 15.4. Merck & Co., Inc.
• 15.5. IDEXX
• 15.6. Apex Bio Medicals
• 15.7. SOUND
• 15.8. GE HealthCare
• 15.9. FUJIFILM Holdings America Corporation
• 15.10. ESAOTE SPA

16. Strategic Recommendations

17. About Us & Disclaimer